| Literature DB >> 24132726 |
Palak Choksi1, Margaret Williams, Patricia M Clark, Catherine Van Poznak.
Abstract
Breast cancer and osteoporosis are common diagnoses in women. Breast cancer survival has improved due to earlier detection and improved treatments. As most breast cancers are estrogen receptor positive, treatment is often aimed at altering the hormonal environment. Both pre and postmenopausal women undergoing these therapies are at risk for bone loss. The patient's health care team ought to have an awareness of the potential for breast cancer treatments to accelerate bone loss. Women with early stage breast cancer are treated with curative intent and, therefore, maintaining bone health is important and is part of the survivorship care to ensure an optimal quality of life.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24132726 PMCID: PMC3949606 DOI: 10.1007/s11914-013-0179-7
Source DB: PubMed Journal: Curr Osteoporos Rep ISSN: 1544-1873 Impact factor: 5.096